Piper Sandler Maintains Overweight on Privia Health Gr, Lowers Price Target to $35
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Piper Sandler analyst Sean Wieland maintains Privia Health Gr (NASDAQ:PRVA) with a Overweight and lowers the price target from $36 to $35.
Piper Sandler analyst Sean Wieland maintains Privia Health Gr (NASDAQ:PRVA) with a Overweight and lowers the price target from $36 to $35.